Sort   by:  
 Page size 
UnknownEffects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease.
Not available
S-EPMC3877372 | biostudies-literature
UnknownThe mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function.
Not available
S-EPMC4262609 | biostudies-literature
UnknownPatient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
Not available
S-EPMC5113698 | biostudies-literature
UnknownOverrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies.
Not available
S-EPMC3995778 | biostudies-literature
UnknownEpidemic spreading model to characterize misfolded proteins propagation in aging and associated neurodegenerative disorders.
Not available
S-EPMC4238950 | biostudies-literature
UnknownCerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.
Not available
S-EPMC4119225 | biostudies-literature
UnknownPatient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
Not available
S-EPMC5134995 | biostudies-literature
UnknownGenetic architecture of resilience of executive functioning.
Not available
S-EPMC3607298 | biostudies-literature
UnknownFunctional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study).
Not available
S-EPMC9543725 | biostudies-literature
UnknownMachine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects.
Not available
S-EPMC5957071 | biostudies-literature
Sort   by:  
 Page size